Psoriasis Clinical Trial Results

Browse clinical trials for Psoriasis by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study P
  Phase 2 · UCB Biopharma SRL · Completed · May 18, 2026
• A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic
  Phase 3 · Janssen Pharmaceutical K.K. · Active, not recruiting · Jan 28, 2026
• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
  Phase 2 · Janssen Research & Development, LLC · Completed · Jul 23, 2026
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic
  Phase 3 · UCB Biopharma SRL · Completed · Oct 16, 2024
• A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arth
  Phase 3 · UCB Biopharma SRL · Completed · Oct 23, 2024
• The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
  Phase 2 · Hangzhou Highlightll Pharmaceutical Co., Ltd · Completed · Jul 21, 2026
• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who
  Phase 3 · AbbVie · Completed · Mar 2, 2022
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Jun 25, 2026
• Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-T
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Dec 8, 2025
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADV
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Jun 25, 2026
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Feb 4, 2026
• A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Jun 1, 2026
• A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Jun 25, 2026
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for t
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Mar 28, 2025
• Diet Interventions in Psoriatic Arthritis
  N/A · University of Pennsylvania · Completed · Jun 29, 2026

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials